EUR 28.5
(-0.35%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 229.88 Million EUR | 19.11% |
2022 | 192.99 Million EUR | 3.85% |
2021 | 185.84 Million EUR | 12.88% |
2020 | 164.63 Million EUR | 5.57% |
2019 | 155.95 Million EUR | 38.75% |
2018 | 112.4 Million EUR | 7.56% |
2017 | 104.5 Million EUR | 1.75% |
2016 | 102.7 Million EUR | 96.31% |
2015 | 52.31 Million EUR | 4.39% |
2014 | 50.11 Million EUR | 12.37% |
2013 | 44.59 Million EUR | 1.15% |
2012 | 44.08 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 235.82 Million EUR | 0.0% |
2024 Q1 | 235.82 Million EUR | 2.58% |
2023 Q2 | 214.43 Million EUR | 0.0% |
2023 Q3 | 215.44 Million EUR | 0.47% |
2023 Q4 | 229.88 Million EUR | 6.7% |
2023 FY | 229.88 Million EUR | 19.11% |
2023 Q1 | 214.43 Million EUR | 11.11% |
2022 Q2 | 188.78 Million EUR | 0.0% |
2022 Q3 | 192.99 Million EUR | 2.23% |
2022 Q1 | 188.78 Million EUR | 1.58% |
2022 FY | 192.99 Million EUR | 3.85% |
2022 Q4 | 192.99 Million EUR | 0.0% |
2021 Q1 | 175.3 Million EUR | 6.48% |
2021 FY | 185.84 Million EUR | 12.88% |
2021 Q4 | 185.84 Million EUR | 0.0% |
2021 Q3 | 185.84 Million EUR | 6.02% |
2021 Q2 | 175.3 Million EUR | 0.0% |
2020 Q4 | 164.63 Million EUR | -0.94% |
2020 Q1 | 163.97 Million EUR | 5.14% |
2020 Q2 | 163.97 Million EUR | 0.0% |
2020 Q3 | 166.19 Million EUR | 1.35% |
2020 FY | 164.63 Million EUR | 5.57% |
2019 Q2 | 152.39 Million EUR | 0.0% |
2019 FY | 155.95 Million EUR | 38.75% |
2019 Q4 | 155.95 Million EUR | 0.0% |
2019 Q3 | 155.95 Million EUR | 2.34% |
2019 Q1 | 152.39 Million EUR | 35.58% |
2018 Q4 | 112.4 Million EUR | 0.06% |
2018 FY | 112.4 Million EUR | 7.56% |
2018 Q3 | 112.32 Million EUR | 0.0% |
2018 Q1 | - EUR | 0.0% |
2017 FY | 104.5 Million EUR | 1.75% |
2016 FY | 102.7 Million EUR | 96.31% |
2015 FY | 52.31 Million EUR | 4.39% |
2014 FY | 50.11 Million EUR | 12.37% |
2013 FY | 44.59 Million EUR | 1.15% |
2012 FY | 44.08 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|